168
J. Ratniyom et al. / Journal of Organometallic Chemistry 752 (2014) 161e170
4.5.4. Synthesis of palladium complex (3d)
4.5.8. Synthesis of palladium complex (3h)
((1-(2,6-Diisopropylphenyl)-1H-imidazol-2-yl)methylene)-4-
nitroaniline ligand was prepared from 1 (76.9 mg, 0.3 mmol,
1.0 equiv) and p-nitroaniline (41.4 mg, 0.3 mmol, 1.0 equiv) in
MeOH (6 mL, 0.05 M). The crude imine ligand was reacted with
(COD)PdCl2 (86.2 mg, 0.3 mmol, 1.0 equiv) in chloroform (6 mL,
0.05 M) following the general procedure for the preparation of
palladium complexes to afford complex 3d as an orange solid
((1-(2,6-Diisopropylphenyl)-1H-imidazol-2-yl)methylene) ada-
mantylamine ligand was prepared from 1 (89.7 mg, 0.35 mmol,
1.0 equiv) and 1-adamantylamine (52.9 mg, 0.35 mmol, 1.0 equiv)
in MeOH (7 mL, 0.05 M). The crude imine ligand was reacted with
(COD)PdCl2 (100 mg, 0.35 mmol, 1.0 equiv) in chloroform (7 mL,
0.05 M) following the general procedure for the preparation of
palladium complexes to afford complex 3h as a red microcrystalline
(110 mg, 66%). 1H NMR (300 MHz, CDCl3):
d
¼ 8.21 (d, J ¼ 9.0 Hz,
(86.7 mg, 87%). 1H NMR (400 MHz, CDCl3):
d
¼ 7.79 (d, J ¼ 1.6 Hz,
2H), 7.85 (d, J ¼ 1.2 Hz, 1H), 7.62e7.57 (m, 2H), 7.49 (d, J ¼ 9.0 Hz,
1H), 7.61 (t, J ¼ 7.7 Hz, 1H), 7.37 (d, J ¼ 7.7 Hz, 2H), 7.20 (s, 1H), 7.07
2H), 7.37 (d, J ¼ 7.8 Hz, 2H), 2.41 (sept, J ¼ 6.8 Hz, 2H), 1.22e1.18 (m,
(d, J ¼ 1.6 Hz, 1H), 2.27 (sept, J ¼ 7.0 Hz, 2H), 2.18 (m, 3H), 2.09 (m,
12H). 13C NMR (75 MHz, CDCl3):
d
¼ 153.1, 150.9, 147.6, 147.3, 146.0,
6H), 1.70 (m, 6H), 1.20 (d, J ¼ 7.0 Hz, 6H), 1.14 (d, J ¼ 7.0 Hz, 6H). 13
C
132.3, 130.9, 129.9, 129.6, 126.9, 125.1, 125.0, 124.1, 28.6, 24.8, 24.3.
HRMS (ESI): calcd. for C22H24Cl2N4O2Pd [M þ Na]þ 577.0202,
Found: 577.0202.
NMR (75 MHz, CDCl3):
d
¼ 147.9, 147.7, 145.8, 132.1, 129.7, 129.5,
124.9, 124.1, 67.0, 42.1, 35.5, 29.5, 28.5, 24.31, 24.30. Anal. Calcd. for
26H35Cl2N3Pd; C, 55.09; H, 6.22; N, 7.41. Found: C, 55.16; H, 6.59; N,
C
7.31.
4.5.5. Synthesis of palladium complex (3e)
((1-(2,6-Diisopropylphenyl)-1H-imidazol-2-yl)methylene)
methylamine ligand was prepared from 1 (64 mg, 0.25 mmol,
4.6. General procedure for screening of palladium complexes for
SuzukieMiyaura cross coupling reaction (Table 1)
1.0 equiv) and 40 %w/w methylamine solution (22 mL, 0.25 mmol,
In the air condition, a 10 mL vial equipped with a magnetic stir
bar was charged with Pd complexes (1.5 mol%), hexame-
thylbenzene (0.05 mmol, 0.0081 g, 0.1 equiv) phenyl boronic acid
(0.6 mmol, 0.073 g, 1.2 equiv), K2CO3 (1.1 mmol, 0.153 g, 2.2 equiv)
and p-bromoanisole (0.5 mmol, 0.062 mL, 1.0 equiv). MeOH (2 mL)
and water (0.5 mL) were mixed and added to the reaction mixture.
The reaction vial was capped and vigorously stirred at room tem-
perature for 24 h. The reaction mixture was extracted with CH2Cl2
(3 ꢃ 10 mL), washed with water (2 ꢃ 10 mL), brine (1 ꢃ10 mL) and
dried over Na2SO4. Solvent was then evaporated. The reaction was
monitored by GC-FID to determine the yield of the product based
on integration relative to hexamethylbenzene as an internal
standard.
1.0 equiv) in MeOH (4 mL, 0.05 M). The crude imine ligand was
reacted with (COD)PdCl2 (71.8 mg, 0.25 mmol, 1.0 equiv) in chlo-
roform (5 mL, 0.05 M) following the general procedure for the
preparation of palladium complexes to afford complex 3e as a
yellow solid (99.3 mg, 89%). 1H NMR (300 MHz, CDCl3):
d
¼ 7.68 (d,
J ¼ 1.4 Hz,1H), 7.59 (t, J ¼ 7.8 Hz,1H), 7.45 (m,1H), 7.37 (d, J ¼ 7.8 Hz,
2H), 7.14 (d, J ¼ 1.4 Hz, 1H), 3.70 (s, 3H), 2.31 (sept, J ¼ 6.8 Hz, 2H),
1.20e1.16 (m, 12H). 13C NMR (75 MHz, CDCl3):
d
¼ 152.8, 147.2,
145.8, 132.1, 129.7, 129.6, 124.8, 49.1, 28.5, 24.7, 24.1. Anal. Calcd. for
17H23Cl2N3Pd: C, 45.71; H, 5.19; N, 9.41. Found: C, 45.77; H, 5.21; N,
C
9.22.
4.5.6. Synthesis of palladium complex (3f)
((1-(2,6-Diisopropylphenyl)-1H-imidazol-2-yl)methylene)
cyclohexylamine ligand was prepared from 1 (128 mg, 0.3 mmol,
1.0 equiv) and cyclohexylamine (34.4 mL, 0.3 mmol, 1.0 equiv) in
MeOH (6 mL, 0.05 M). The crude imine ligand was reacted with
(COD)PdCl2 (86.2 mg, 0.3 mmol, 1.0 equiv) in chloroform (5 mL,
0.05 M) following the general procedure for the preparation of
palladium complexes to afford complex 3f as a red crystalline
4.7. General procedure for the investigation of the effect of catalyst
loading, base, solvent, time and substrate scopes on Suzukie
Miyaura cross coupling reaction (Tables S1eS5, Tables 4 and 5)
In the air condition, hexamethylbenzene (0.05 mmol, 0.0081 g,
0.1 equiv), aryl halide (0.5 mmol, 1 equiv), aryl boronic acid
(0.6 mmol, 1.2 equiv), base (1.1 mmol, 2.2 equiv) and solvent was
subsequently added into a 10 mL vial equipped with a magnetic
stir bar. The 5 mM Pd catalyst solution in MeOH was added as
indicated in the table. The reaction vial was capped and vigorously
stirred at room temperature for desired time as indicated. The
reaction mixture was extracted with CH2Cl2 (3 ꢃ 10 mL), washed
with water (2 ꢃ 10 mL), brine (1 ꢃ 10 mL) and dried over Na2SO4.
The combined organic phase was then concentrated to afford the
crude coupling product. The reaction was monitored by GC-FID
based on integration relative to hexamethylbenzene as an inter-
nal standard. The crude product was finally isolated by column
chromatography (0e10%: EtOAc/hexane) to afford the desired
product.
(149.9 mg, 97%). 1H NMR (300 MHz, CDCl3):
d
¼ 7.69 (d,
J ¼ 1.4 Hz, 1H), 7.60 (t, J ¼ 7.8 Hz, 1H), 7.36 (d, J ¼ 7.8 Hz, 2H), 7.28
(m, 1H), 7.14 (d, J ¼ 1.4 Hz, 1H), 4.29 (m, 1H), 2.30e2.20 (m, 4H),
1.81e1.65 (m, 4H), 1.41 (m, 2H), 1.19e1.10 (m, 12H), 1.04e0.99 (m,
2H). 13C NMR (75 MHz, CDCl3):
129.6, 129.4, 124.9, 124.6, 65.5, 33.8, 28.4, 25.1, 25.0, 24.2. HRMS
(ESI): calcd. for C22H31Cl2N3Pd [M þ Na]þ 538.0820, Found:
538.0820.
d
¼ 148.7, 147.9, 145.6, 132.1,
4.5.7. Synthesis of palladium complex (3g)
((1-(2,6-Diisopropylphenyl)-1H-imidazol-2-yl)methylene)-tert-
butylamine ligand was prepared from 1 (64 mg, 0.25 mmol,
1.0 equiv) and tert-butylamine (26.4 mL, 0.25 mmol, 1.0 equiv) in
MeOH (4 mL, 0.05 M). The crude imine ligand was reacted with
(COD)PdCl2 (71.8 mg, 0.25 mmol, 1.0 equiv) in chloroform (5 mL,
0.05 M) following the general procedure for the preparation of
palladium complexes to afford complex 3g as a red crystalline
4.8. Analytical data of coupling products (4aeq)
4.8.1. Biphenyl (4a, Table 4, entry 1)
1H NMR (300 MHz, CDCl3):
d
¼ 7.65 (d, J ¼ 7.7 Hz, 4H), 7.49 (t,
(93.9 mg, 75%). 1H NMR (300 MHz, CDCl3):
d
¼ 7.78 (d, J ¼ 1.4 Hz,
J ¼ 7.7 Hz, 4H), 7.37 (m, 2H). EI-MS (m/z, relative intensity): 155
1H), 7.61 (t, J ¼ 7.8 Hz, 1H), 7.37 (d, J ¼ 7.8 Hz, 2H), 7.26 (m, 1H), 7.11
(d, J ¼ 1.4 Hz, 1H), 2.26 (sept, J ¼ 6.7 Hz, 2H), 1.54 (s, 9H), 1.19 (d,
J ¼ 6.7 Hz, 6H), 1.12 (d, J ¼ 6.7 Hz, 6H). 13C NMR (75 MHz, CDCl3):
(14), 154 (Mþ, 100), 153 (42), 152 (29). CAS Number: 92-52-4.
4.8.2. 4-Methoxybiphenyl (4b, Table 4, entries 2 and 5; Table 5,
d
¼ 147.7, 147.6, 145.6, 132.2, 129.6, 129.5, 124.9, 124.4, 66.7, 29.6,
entry 1)
28.4, 24.3, 24.2. Anal. Calcd. for C20H29Cl2N3Pd: C, 49.14; H, 5.98; N,
8.60. Found: C, 49.28; H, 6.03; N, 8.48.
1H NMR (300 MHz, CDCl3):
J ¼ 7.5 Hz, 2H), 7.35e7.28 (m, 1H), 7.00 (d, J ¼ 8.7 Hz, 2H), 3.88 (s,
d
¼ 7.57 (t, J ¼ 8.7 Hz, 4H), 7.44 (t,